US Patent Issued to ACCESS TO ADVANCED HEALTH INSTITUTE on Dec. 9 for "Formulation containing TLR agonist and methods of use" (Washington Inventor)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,243, issued on Dec. 9, was assigned to ACCESS TO ADVANCED HEALTH INSTITUTE (Seattle).

"Formulation containing TLR agonist and methods of use" was invented by Christopher B. Fox (Sumner, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Stable aqueous formulations of adjuvant comprising a TLR7/8 agonist or a TLR4 agonist with a helper lipid that are adsorbed to alum are provided. Compositions and methods of using the formulations for stimulating an immune response are also provided."

The patent was filed on April 28, 2022, under Application No. 17/731,718.

*For further information, including images, charts and tables, please visit: http://patft.u...